Last Updated: May 6, 2026

TAMSULOSIN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Tamsulosin, and when can generic versions of Tamsulosin launch?

Tamsulosin is a drug marketed by Alkem Labs Ltd, Ascent Pharms Inc, Aurobindo Pharma Ltd, Chartwell Rx, Impax Labs, Macleods Pharms Ltd, Ph Health, Pharmobedient, Rising, Sandoz, Sciegen Pharms, Sun Pharm Inds Ltd, Synthon Bv, Teva Pharms, and Zydus Pharms Usa Inc. and is included in fifteen NDAs.

The generic ingredient in TAMSULOSIN is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tamsulosin

A generic version of TAMSULOSIN was approved as tamsulosin hydrochloride by IMPAX LABS on March 2^nd, 2010.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for TAMSULOSIN?
What are the global sales for TAMSULOSIN?
What is Average Wholesale Price for TAMSULOSIN?

Summary for TAMSULOSIN

US Patents:	0
Applicants:	15
NDAs:	15
Drug Prices:	Drug price information for TAMSULOSIN
Drug Sales Revenues:	Drug sales revenues for TAMSULOSIN
DailyMed Link:	TAMSULOSIN at DailyMed

Drug patent expirations by year for TAMSULOSIN

Drug Prices for TAMSULOSIN

US Patents and Regulatory Information for TAMSULOSIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alkem Labs Ltd	TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	207405-001	Aug 11, 2017	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ph Health	TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	202010-001	Jan 4, 2013		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Chartwell Rx	TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	211885-001	Oct 17, 2019	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for TAMSULOSIN

Can I request help getting Tamsulosin?
Which companies led in tamsulosin production in 2020?
Which drug makers had the highest tamsulosin sales in 2020?
How much did tamsulosin sales grow in 2020?
Who were the top drug makers for tamsulosin revenue in 2020?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.